The DOI matches its Crossref record; 326 of the 326 references it cites were found in a registry or an index.
Antidepressants for smoking cessation
Open accessAbstract
BACKGROUND: There are at least three reasons to believe antidepressants might help in smoking cessation. Firstly, nicotine withdrawal may produce depressive symptoms or precipitate a major depressive episode and antidepressants may relieve these. Secondly, nicotine may have antidepressant effects that maintain smoking, and antidepressants may substitute for this effect. Finally, some antidepressants may have a specific effect on neural pathways (e.g. inhibiting monoamine oxidase) or receptors (e.g. blockade of nicotinic-cholinergic receptors) underlying nicotine addiction. OBJECTIVES: The aim of this review is to assess the effect and safety of antidepressant medications to aid long-term smoking cessation. The medications include bupropion; doxepin; fluoxetine; imipramine; lazabemide; moclobemide; nortriptyline; paroxetine; S-Adenosyl-L-Methionine (SAMe); selegiline; sertraline; St. John's wort; tryptophan; venlafaxine; and zimeledine. SEARCH METHODS: We searched the Cochrane Tobacco Addiction Group Specialised Register which includes reports of trials indexed in the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, and PsycINFO, and other reviews and meeting abstracts, in July 2013. SELECTION CRITERIA: We considered randomized trials comparing antidepressant medications to placebo or an alternative pharmacotherapy for smoking cessation. We also included trials comparing different doses, using pharmacotherapy to prevent relapse or re-initiate smoking cessation or to help smokers reduce cigarette consumption. We excluded trials with less than six months follow-up. DATA COLLECTION AND ANALYSIS: We extracted data and assessed risk of bias using standard methodological procedures expected by the Cochrane Collaboration.The main outcome measure was abstinence from smoking after at least six months follow-up in patients smoking at baseline, expressed as a risk ratio (RR). We used the most rigorous definition of abstinence available in each trial, and biochemically validated rates if available. Where appropriate, we performed meta-analysis using a fixed-effect model. MAIN RESULTS: Twenty-four new trials were identified since the 2009 update, bringing the total number of included trials to 90. There were 65 trials of bupropion and ten trials of nortriptyline, with the majority at low or unclear risk of bias. There was high quality evidence that, when used as the sole pharmacotherapy, bupropion significantly increased long-term cessation (44 trials, N = 13,728, risk ratio [RR] 1.62, 95% confidence interval [CI] 1.49 to 1.76). There was moderate quality evidence, limited by a relatively small number of trials and participants, that nortriptyline also significantly increased long-term cessation when used as the sole pharmacotherapy (six trials, N = 975, RR 2.03, 95% CI 1.48 to 2.78). There is insufficient evidence that adding bupropion (12 trials, N = 3487, RR 1.9, 95% CI 0.94 to 1.51) or nortriptyline (4 trials, N = 1644, RR 1.21, 95% CI 0.94 to 1.55) to nicotine replacement therapy (NRT) provides an additional long-term benefit. Based on a limited amount of data from direct comparisons, bupropion and nortriptyline appear to be equally effective and of similar efficacy to NRT (bupropion versus nortriptyline 3 trials, N = 417, RR 1.30, 95% CI 0.93 to 1.82; bupropion versus NRT 8 trials, N = 4096, RR 0.96, 95% CI 0.85 to 1.09; no direct comparisons between nortriptyline and NRT). Pooled results from four trials comparing bupropion to varenicline showed significantly lower quitting with bupropion than with varenicline (N = 1810, RR 0.68, 95% CI 0.56 to 0.83). Meta-analyses did not detect a significant increase in the rate of serious adverse events amongst participants taking bupropion, though the confidence interval only narrowly missed statistical significance (33 trials, N = 9631, RR 1.30, 95% CI 1.00 to 1.69). There is a risk of about 1 in 1000 of seizures associated with bupropion use. Bupropion has been associated with suicide risk, but whether this is causal is unclear. Nortriptyline has the potential for serious side-effects, but none have been seen in the few small trials for smoking cessation.There was no evidence of a significant effect for selective serotonin reuptake inhibitors on their own (RR 0.93, 95% CI 0.71 to 1.22, N = 1594; 2 trials fluoxetine, 1 paroxetine, 1 sertraline) or as an adjunct to NRT (3 trials of fluoxetine, N = 466, RR 0.70, 95% CI 0.64 to 1.82). Significant effects were also not detected for monoamine oxidase inhibitors (RR 1.29, 95% CI 0.93 to 1.79, N = 827; 1 trial moclobemide, 5 selegiline), the atypical antidepressant venlafaxine (1 trial, N = 147, RR 1.22, 95% CI 0.64 to 2.32), the herbal therapy St John's wort (hypericum) (2 trials, N = 261, RR 0.81, 95% CI 0.26 to 2.53), or the dietary supplement SAMe (1 trial, N = 120, RR 0.70, 95% CI 0.24 to 2.07). AUTHORS' CONCLUSIONS: The antidepressants bupropion and nortriptyline aid long-term smoking cessation. Adver
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–326 of 326
Monuteaux, M. C., Spencer, T. J., Faraone, S. V., Wilson, A., & Biederman, J. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0718 · Cited by 48
Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation.
Cinciripini, P. M., Tsoh, J. Y., Wetter, D. W., Lam, C. Y., de Moor, C., Cinciripini, L. G., Baile, W. F., Anderson, C. B., & Minna, J. D. (2005) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.13.4.282 · Cited by 48
Joint effect of dopaminergic genes on likelihood of smoking following treatment with bupropion SR.
Swan, G. E., Jack, L. M., Valdes, A. M., Ring, H. Z., Ton, C. C. T., Curry, S. J., & McAfee, T. A. (2007) · Health Psychology · doi:10.1037/0278-6133.26.3.361 · Cited by 48
Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial using bupropion
Wileyto, E. P., Patterson, F., NIAURA, R. S., Epstein, L. H., Brown, R. A., Audrain-McGovern, J. E., Hawk, L. W., & Lerman, C. E. (2005) · Nicotine & Tobacco Research · doi:10.1080/14622200500055673 · Cited by 48
Bupropion and nicotine patch as smoking cessation aids in alcoholics
Grant, K. M., Kelley, S. S., Smith, L. M., Agrawal, S., Meyer, J. R., & Romberger, D. J. (2007) · Alcohol · doi:10.1016/j.alcohol.2007.03.011 · Cited by 48
Jacobs, M. A., Spilken, A. Z., Norman, M. M., Wohlberg, G. W., & Knapp, P. H. (1971) · Psychosomatic Medicine · doi:10.1097/00006842-197111000-00007 · Cited by 48
A Preliminary Study of Sustained-Release Bupropion for Smoking Cessation in Bipolar Disorder
Weinberger, A. H., Vessicchio, J. C., Sacco, K. A., Creeden, C. L., Chengappa, K. N. R., & George, T. P. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318184ba3c · Cited by 47
Issues related to implementing a smoking cessation clinical trial for cancer patients
Martinez, E., Tatum, K. L., Weber, D. M., Kuzla, N., Pendley, A., Campbell, K. A., Ridge, J. A., Langer, C. J., Miyamoto, C. T., & Schnoll, R. A. (2008) · Cancer Causes & Control · doi:10.1007/s10552-008-9222-x · Cited by 47
Rovina, N., Nikoloutsou, I., Katsani, G., Dima, E., Fransis, K., Roussos, C., & Gratziou, C. (2009) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465809350653 · Cited by 47
Lazabemide, a selective, reversible monoamine oxidase B inhibitor, as an aid to smoking cessation
Berlin, I., Aubin, H., Pedarriosse, A., Rames, A. D., Lazabemide in Smoking Cessation Study Investigators, Lancrenon, S., & Lagrue, G. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00258.x · Cited by 47
Influence of fluoxetine on positive and negative affect in a clinic-based smoking cessation trial
Cook, J. W., Spring, B., McChargue, D. E., Borrelli, B., Hitsman, B., Niaura, R., Keuthen, N. J., & Kristeller, J. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1711-8 · Cited by 46
Covey, L. S., Botello-Harbaum, M., Glassman, A. H., Masmela, J. R., LoDuca, C., Salzman, V., & Fried, J. (2008) · PubMed · doi:10.13016/hqdt-xphk · Cited by 46
Smoking Cessation After Acute Myocardial Infarction
Benowitz, N. L., & Prochaska, J. J. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.017 · Cited by 45
Gold, P. B., Rubey, R. N., & Harvey, R. T. (2002) · American Journal on Addictions · doi:10.1080/1055049029008811 · Cited by 45
An Employer-Based Cost-Benefit Analysis of a Novel Pharmacotherapy Agent for Smoking Cessation
Jackson, K. C., Nahoopii, R., Said, Q., Dirani, R. D., & Brixner, D. I. (2007) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0b013e3180459ff2 · Cited by 44
Bupropion Sustained Release Added to Group Support for Smoking Cessation in Schizophrenia
Weiner, E., Ball, M. P., Buchholz, A. S., Gold, J. M., Evins, A. E., McMahon, R. P., & Buchanan, R. W. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06143gre · Cited by 44
Bupropion and cognitive-behavioral therapy for smoking cessation in women
Schmitz, J. M., Stotts, A. L., Mooney, M. E., DeLaune, K. A., & Moeller, G. F. (2007) · Nicotine & Tobacco Research · doi:10.1080/14622200701365335 · Cited by 44
A randomized controlled trial of a smoking cessation intervention conducted among prisoners
RICHMOND, R. L., Indig, D., Butler, T. G., Wilhelm, K. A., Archer, V., & WODAK, A. D. (2012) · Addiction · doi:10.1111/add.12084 · Cited by 43
Bupropion May Support Psychosocial Treatment of Nicotine‐Dependent Adolescents: Preliminary Results
Niederhofer, H., & Huber, M. K. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.16.1524.50953 · Cited by 43
Bupropion SR for the treatment of smokeless tobacco use
Dale, L. C., Ebbert, J. O., Glover, E. D., Croghan, I. T., Schroeder, D. R., Severson, H. H., & Hurt, R. D. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.02.008 · Cited by 43
Hilberink, S. R., Jacobs, J., BRETELER, M. H. M., de Vries, H., & Grol, R. P. T. M. (2010) · Patient Education and Counseling · doi:10.1016/j.pec.2010.04.009 · Cited by 43
Fluoxetine, smoking, and history of major depression: A randomized controlled trial.
Spring, B. J., Doran, N., Pagoto, S., McChargue, D. E., Cook, J. W., Bailey, K. C., Crayton, J. W., & Hedeker, D. (2007) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.75.1.85 · Cited by 43
Gawin, F. H., Compton, M., & Byck, R. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810030094013 · Cited by 43
Preliminary Study of Buprenorphine and Bupropion for Opioid‐Dependent Smokers
Mooney, M. E., Poling, J. C., Gonzalez, G. M., Gonsai, K., Kosten, T. R., & Sofuoglu, M. (2008) · American Journal on Addictions · doi:10.1080/10550490802138814 · Cited by 43
Bupropion for the treatment of nicotine dependence in spit tobacco users: a pilot study
Dale, L. C., Ebbert, J. O., Schroeder, D. R., Croghan, I. T., Rasmussen, D. F., Trautman, J. A., Cox, L. S., & Hurt, R. D. (2002) · Nicotine & Tobacco Research · doi:10.1080/14622200210153821 · Cited by 43
Weight suppression and weight rebound in ex-smokers treated with fluoxetine.
Borrelli, B., Spring, B. J., NIAURA, R. S., Kristeller, J. L., Ockene, J. K., & Keuthen, N. J. (1999) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.67.1.124 · Cited by 42
Bupropion as an aid to smoking cessation: a review of real-life effectiveness
Holmes, S., Zwar, N. A., Jimenez-Ruiz, C. A., Ryan, P. J., Browning, D., Bergmann, L., & Johnston, J. A. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2004.00153.x · Cited by 41
Fossati, R., Apolone, G., Negri, E., Compagnoni, A., Vecchia, C. L., Mangano, S., Clivio, L., & Garattini, S. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.16.1791 · Cited by 41
Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation
Leventhal, A. M., David, S. P., Brightman, M., Strong, D. R., McGeary, J. E., Brown, R. A., Lloyd‐Richardson, E. E., Munafo, M. R., Uhl, G. R., & NIAURA, R. S. (2010) · The Pharmacogenomics Journal · doi:10.1038/tpj.2010.64 · Cited by 41
A randomized trial of short psychotherapy versus sustained‐release bupropion for smoking cessation
Zernig, G., Wallner, R., Grohs, U., Kriechbaum, N., Kemmler, G., & Saria, A. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02348.x · Cited by 41
Weinberger, A. H., Reutenauer, E. L., Jatlow, P. I., O’Malley, S. S., Potenza, M. N., & George, T. P. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.10.009 · Cited by 41
Borrelli, B., Papandonatos, G. D., Spring, B. J., Hitsman, B. L., & NIAURA, R. S. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00648.x · Cited by 40
A Comparison of Sustained-release Bupropion and Placebo for Smokeless Tobacco Cessation
Glover, E. D., Glover, P. N., Sullivan, C. R., Cerullo, C. L., & Hobbs, G. R. (2002) · American Journal of Health Behavior · doi:10.5993/ajhb.26.5.7 · Cited by 40
Kotz, D., Wesseling, G., Huibers, M. J. H., & van Schayck, O. C. P. (2007) · BMC Public Health · doi:10.1186/1471-2458-7-332 · Cited by 39
No Evidence for a Major Role of Polymorphisms During Bupropion Treatment
Hu, J., Redden, D. T., Berrettini, W. H., Shields, P. G., Restine, S. L., Pinto, A., Lerman, C. E., & Allison, D. B. (2006) · Obesity · doi:10.1038/oby.2006.215 · Cited by 39
Bupropion SR vs Placebo for Smoking Cessation in Health Care Professionals
Zellweger, J.-P., Boelcskei, P. L., Carrozzi, L., Sepper, R., Sweet, R., & Hider, A. (2005) · American Journal of Health Behavior · doi:10.5993/ajhb.29.3.5 · Cited by 39
Effects of doxepin on withdrawal symptoms in smoking cessation
Murphy, J. K., Edwards, N. B., Downs, A. D., Ackerman, B. J., & Rosenthal, T. L. (1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.10.1353 · Cited by 39
Fatemi, S. H., Stary, J. M., Hatsukami, D. K., & Murphy, S. E. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.02.021 · Cited by 38
Welton, N. J., Johnstone, E. C., David, S. P., & Munafo, M. R. (2008) · Nicotine & Tobacco Research · doi:10.1080/14622200701767761 · Cited by 38
Wittchen, H., Hoch, E., Klotsche, J., & Muehlig, S. (2011) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.328 · Cited by 38
Do small lapses predict relapse to smoking behavior under bupropion treatment?
Wileyto, P., Patterson, F., NIAURA, R. S., Epstein, L. H., Brown, R. A., Audrain-McGovern, J. E., Hawk, L. W., Lerman, C. E., & Patterson, F. (2004) · Nicotine & Tobacco Research · doi:10.1080/1462220042000202463 · Cited by 38
Double-blind fluoxetine in depressed alcoholic smokers.
Cornelius, J. R., Salloum, I. M., Ehler, J. G., Jarrett, P. J., Cornelius, M. D., Black, A., Perel, J. M., & Thase, M. E. (1997) · PubMed · Cited by 37
Do Serotonin Uptake Inhibitors Decrease Smoking? Observations in a Group of Heavy Drinkers
Sellers, E. M., Naranjo, C. A., & Kadlec, K. E. (1987) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198712000-00009 · Cited by 37
Effects of fluoxetine on weight gain and food intake in smokers who reduce nicotine intake
Pomerleau, O. F., Pomerleau, C. S., Morrell, E. M., & Lowenbergh, J. M. (1991) · Psychoneuroendocrinology · doi:10.1016/0306-4530(91)90008-h · Cited by 37
Subjective sleep disturbance during a smoking cessation program: Associations with relapse
Okun, M. L., Levine, M. D., Houck, P. R., Perkins, K. A., & Marcus, M. D. (2011) · Addictive Behaviors · doi:10.1016/j.addbeh.2011.03.001 · Cited by 37
Martínez-Raga, J., Keaney, F., Sutherland, G., Gálvez, B. P., & Strang, J. (2003) · Addiction Biology · doi:10.1080/1355621031000069837 · Cited by 36
The Cost Utility of Bupropion in Smoking Cessation Health Programs
Bolin, K., Lindgren, B., & Willers, S. (2006) · CHEST Journal · doi:10.1378/chest.129.3.651 · Cited by 36
Bupropion SR for smoking cessation
West, R. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.4.533 · Cited by 36
Impact of Prior Nicotine Replacement Therapy on Smoking Cessation Efficacy
Durcan, M. J., White, J. D., Johnston, J. A., Nides, M. A., Jorenby, D. E., Fiore, M. C., Leischow, S. J., Ascher, J. A., & Rennard, S. I. (2002) · American Journal of Health Behavior · doi:10.5993/ajhb.26.3.6 · Cited by 36
Berlin, I., Spreux‐Varoquaux, O., Saïd, S., & Launay, J. (1997) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(97)01338-0 · Cited by 35
Grassi, M. C., Enea, D., Ferketich, A. K., Lu, B., & Nencini, P. (2009) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntp110 · Cited by 35
Croghan, I. T., Hurt, R. D., Ebbert, J. O., Croghan, G. A., Polk, O. D., Stella, P. J., Novotny, P. J., Sloan, J. A., & Loprinzi, C. L. (2009) · Journal of Public Health · doi:10.1007/s10389-009-0277-2 · Cited by 34
Kalman, D., Herz, L. R., Monti, P. M., Kahler, C. W., Mooney, M. E., Rodrigues, S., & O’Connor, K. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.03.005 · Cited by 34
Swan, G. E., Jack, L. M., Javitz, H. S., McAfee, T. A., & McClure, J. B. (2008) · CNS Drugs · doi:10.2165/00023210-200822030-00004 · Cited by 34
Elevated positive mood: A mixed blessing for abstinence.
Doran, N., Spring, B. J., Borrelli, B., McChargue, D. E., Hitsman, B. L., NIAURA, R. S., & Hedeker, D. (2006) · Psychology of Addictive Behaviors · doi:10.1037/0893-164x.20.1.36 · Cited by 34
Killen, J. D., Fortmann, S. P., Murphy, G. M., Hayward, C., Fong, D., Lowenthal, K., Bryson, S. W., Killen, D. T., & Schatzberg, A. F. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.03020.x · Cited by 33
Predictors of smoking cessation among cancer patients enrolled in a smoking cessation program
Schnoll, R. A., Martinez, E., Langer, C. J., Miyamoto, C. T., & Leone, F. T. (2011) · Acta Oncologica · doi:10.3109/0284186x.2011.572915 · Cited by 33
Effect of Nonnicotine Pharmacotherapy on Smoking Behavior
Kotlyar, M., Golding, M., Hatsukami, D. K., & Jamerson, B. D. (2001) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.20.1530.34477 · Cited by 32
Jack, L. M., Swan, G. E., Thompson, E., Curry, S. J., McAfee, T. A., Dacey, S., & Bergman, K. (2003) · Preventive Medicine · doi:10.1016/s0091-7435(03)00011-2 · Cited by 32
Use of Sustained-Release Bupropion in Specific Patient Populations for Smoking Cessation
Tonstad, S. (2002) · Drugs · doi:10.2165/00003495-200262002-00004 · Cited by 32
Brown, R. A., Abrantes, A. M., Strong, D. R., NIAURA, R. S., Kahler, C. W., Miller, I. W., & Price, L. H. (2013) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntt134 · Cited by 32
An Evaluation of the Italian Version of the Fagerström Test for Nicotine Dependence
Fekketich, A. K., Fossati, R., & Apolone, G. (2008) · Psychological Reports · doi:10.2466/pr0.102.3.687-694 · Cited by 31
Use of varenicline versus bupropion and risk of psychiatric adverse events
Pasternak, B., Svanström, H., & Hviid, A. P. (2013) · Addiction · doi:10.1111/add.12165 · Cited by 31
Pharmacogenetic Association of the Galanin Receptor (GALR1) SNP rs2717162 with Smoking Cessation
Gold, A. B., Wileyto, E. P., Lori, A., Conti, D. V., Cubells, J. F., & Lerman, C. E. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.13 · Cited by 31
Hays, J. T., Hurt, R. D., Decker, P. A., Croghan, I. T., Offord, K. P., & Patten, C. A. (2009) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntp077 · Cited by 31
Regular Exercise as a Protective Factor in Relapse following Smoking Cessation Treatment
Abrantes, A. M., Strong, D. R., Lloyd‐Richardson, E. E., NIAURA, R. S., Kahler, C. W., & Brown, R. A. (2009) · American Journal on Addictions · doi:10.1080/10550490802545182 · Cited by 30
Bupropion: pharmacological and clinical profile in smoking cessation
Haustein, K.-O. (2003) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp41056 · Cited by 30
A Randomized Clinical Trial of St. John's Wort for Smoking Cessation
Sood, A., Ebbert, J. O., Prasad, K., Croghan, I. T., Bauer, B. A., & Schroeder, D. R. (2010) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2009.0445 · Cited by 29
Cox, L. S., Faseru, B., Mayo, M. S., Krebill, R., Snow, T. M., Bronars, C. A., Nollen, N. L., Choi, W. S., Okuyemi, K. S., Salzman, G. A., et al. (2011) · Trials · doi:10.1186/1745-6215-12-22 · Cited by 29
Sustained-release bupropion for hospital-based smoking cessation: A randomized trial
Simon, J. A., Duncan, C. L., Huggins, J., Solkowitz, S. N., & Carmody, T. P. (2009) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntp047 · Cited by 29
Quaak, M., van Schayck, O. C. P., Postma, D. S., Wagena, E. J., & van Schooten, F. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03534.x · Cited by 28
Measuring nicotine dependence among smokeless tobacco users
Thomas, J., Ebbert, J. O., Patten, C. A., Dale, L. C., Bronars, C. A., & Schroeder, D. R. (2006) · Addictive Behaviors · doi:10.1016/j.addbeh.2005.11.005 · Cited by 28
Lack of effect of D2 dopamine receptor TaqI A polymorphism on smoking cessation
Berlin, I., Covey, L. S., Jiang, H., & Hamer, D. H. (2005) · Nicotine & Tobacco Research · doi:10.1080/14622200500259176 · Cited by 27
McGeary, J. E., Knopik, V. S., Hayes, J. E., Palmer, R. H. C., Monti, P. M., & Kalman, D. (2012) · Substance Abuse Research and Treatment · doi:10.4137/sart.s8866 · Cited by 27
Parsons, A. C., Ingram, J. T., Inglis, J., Aveyard, P. N., Johnstone, E. C., Brown, K. S., Franklin, M., & Bermúdez, I. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.02.006 · Cited by 27
Bloch, B., Reshef, A., Cohen, T. R., Tafla, A., Gathas, S., Israel, S., Gritsenko, I., Kremer, I., & Ebstein, R. P. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.12.015 · Cited by 27
Fluoxetine Versus Placebo to Decrease the Smoking of Depressed Alcoholic Patients
Cornelius, J. R., Perkins, K. A., Salloum, I. M., Thase, M. E., & Moss, H. B. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199904000-00015 · Cited by 27
Swanson, N. A., Burroughs, C. C., Long, M. A. D., & Lee, R. W. (2003) · Military Medicine · doi:10.1093/milmed/168.10.830 · Cited by 27
Siddiqi, K., Khan, A. Z., Ahmad, M., & Shafiq‐ur‐Rehman (2010) · BMC Public Health · doi:10.1186/1471-2458-10-160 · Cited by 26
Schnoll, R. A., Epstein, L. H., Audrain, J. E., NIAURA, R. S., Hawk, L. W., Shields, P. G., Lerman, C. E., & Wileyto, E. P. (2007) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2007.04.004 · Cited by 26
Meta-Analysis of Suicidality in Placebo-Controlled Clinical Trials of Adults Taking Bupropion
Wightman, D. S., Foster, V. J., Krishen, A., Richard, N. E., & Modell, J. G. (2010) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.09m00894blu · Cited by 25
Barnes, J., Barber, N., Wheatley, D., & Williamson, E. M. (2006) · Planta Medica · doi:10.1055/s-2005-916219 · Cited by 25
A randomized, open‐label pilot comparison of gabapentin and bupropion SR for smoking cessation
White, W. D., Crockford, D. N., Patten, S. B., & el‐Guebaly, N. (2005) · Nicotine & Tobacco Research · doi:10.1080/14622200500259887 · Cited by 25
A randomized trial of smoking cessation. Medication versus motivation
Uyar, M., Filiz, A., Bayram, N. G., Elbek, O., Herken, H., Topçu, A., Dikensoy, Ö., & Ekinci, E. (2007) · Saudi Medical Journal · doi:10.15537/1658-3175.3942 · Cited by 24
A Phase II study of St. John's Wort for smoking cessation
Lawvere, S., Mahoney, M. C., Cummings, K. M., Kepner, J. L., Hyland, A. J., Lawrence, D. D., & Murphy, J. M. (2006) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2006.01.007 · Cited by 24
Hitsman, B. L., Spring, B. J., Borrelli, B., NIAURA, R. S., & Papandonatos, G. D. (2001) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.9.4.355 · Cited by 24
Berlin, I., Hunneyball, I. M., Greiling, D., Jones, S. P., FUDER, H., & Stahl, H.-D. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2692-2 · Cited by 23
Outcomes of Bupropion Therapy for Smoking Cessation During Routine Clinical Use
Paluck, E., McCormack, J. P., Ensom, M. H. H., Levine, M., Soon, J. A., & Fielding, D. W. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g324 · Cited by 23
Selegiline Transdermal System (STS) as an Aid for Smoking Cessation
Kahn, R., Gorgon, L., Jones, K. M., McSherry, F., Glover, E. D., Anthenelli, R. M., Jackson, T., Williams, J. M., Murtaugh, C., Montoya, I. D., et al. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr143 · Cited by 23
Kumar, R., & Singh, P. P. (2010) · Lung India · doi:10.4103/0970-2113.59262 · Cited by 22
van Schayck, O. C. P., Kaper, J., Wagena, E. J., Wouters, E. F. �., & Severens, J. L. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02723.x · Cited by 22
Hussain, S., Zawertailo, L. A., Busto, U. E., Zack, M. H., Farvolden, P., & Selby, P. L. (2009) · Addictive Behaviors · doi:10.1016/j.addbeh.2009.09.004 · Cited by 21
Weinberger, A. H., McKee, S. A., & George, T. P. (2010) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntq120 · Cited by 21
Modeling smoking cessation data with alternating states and a cure fraction using frailty models
Li, Y., Wileyto, E. P., & Heitjan, D. F. (2010) · Statistics in Medicine · doi:10.1002/sim.3825 · Cited by 20
Major depression among adolescent smokers undergoing treatment for nicotine dependence
Killen, J. D., Robinson, T. N., Ammerman, S., Hayward, C., Rogers, J., Samuels, D., & Schatzberg, A. F. (2004) · Addictive Behaviors · doi:10.1016/j.addbeh.2004.02.029 · Cited by 19
Therapeutic Drug Monitoring of Nortriptyline in Smoking Cessation: A Multistudy Analysis
Mooney, M., Reus, V. I., Gorecki, J., Hall, S., Humfleet, G. L., Muñoz, R., & Delucchi, K. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100307 · Cited by 19
Thomas, J., Guo, H., Lynam, I. M., Powell, J. N., Okuyemi, K. S., Bronars, C. A., & Ahluwalia, J. S. (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-008-0656-3 · Cited by 19
Buspirone effect on tobacco withdrawal symptoms: a pilot study.
Robinson, M. D., Smith, W. A., Cederstrom, E. A., & Sutherland, D. E. (1991) · PubMed · Cited by 18
Bupropion SR for Relapse Prevention: A “Slips-Allowed“ Analysis
Durcan, M., Johnston, J. A., White, J., Gonzales, D., Sachs, D. P. L., Rigotti, N., & Niaura, R. (2004) · American Journal of Health Behavior · doi:10.5993/ajhb.28.5.8 · Cited by 17
Faseru, B., Choi, W. S., Krebill, R., Mayo, M. S., Nollen, N. L., Okuyemi, K. S., Ahluwalia, J. S., & Cox, L. S. (2011) · Addictive Behaviors · doi:10.1016/j.addbeh.2011.07.015 · Cited by 17
Intention to quit moderates the effect of bupropion on smoking urge
Tidey, J. W., & Rohsenow, D. J. (2009) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntn032 · Cited by 16
Carrão, J. L., Moreira, L. B., & Fuchs, F. D. (2007) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-007-0726-2 · Cited by 15
The dynamics of the urge‐to‐smoke following smoking cessation via pharmacotherapy
Javitz, H. S., Swan, G. E., & Lerman, C. E. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03495.x · Cited by 15
Sheng, L., Tang, Y.-L., Jiang, Z.-N., Yao, C.-H., Gao, J.-Y., Xu, G. Z., & Tong, X.-Y. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts124 · Cited by 14
S -Adenosyl- l -Methionine (SAMe) for Smoking Abstinence: A Randomized Clinical Trial
Sood, A., Prasad, K., Croghan, I. T., Schroeder, D. R., Ehlers, S. L., & Ebbert, J. O. (2012) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2011.0462 · Cited by 13
Karam‐Hage, M., Strobbe, S., Robinson, J. D., & Brower, K. J. (2011) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2011.598591 · Cited by 13
[Effect of treatment for nicotine dependence in patients with COPD].
Górecka, D., Bednarek, M., Nowiński, A., Puścińska, E., Goljan-Geremek, A., & Zielinski, J. (2003) · PubMed · Cited by 12
Bupropion SR for smoking cessation in pregnancy: a pilot study
Miller, H. S., Ranger‐Moore, J., & Hingtgen, M. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2003.10.260 · Cited by 12
Pragmatic, observational study of bupropion treatment for smoking cessation in general practice
Wilkes, S., Evans, A., Henderson, M. A., & Gibson, J. (2005) · Postgraduate Medical Journal · doi:10.1136/pgmj.2005.032433 · Cited by 12
Eisenberg, M. J., Grandi, S. M., Gervais, A., Joseph, L., O’Loughlin, J. L., Paradis, G., Rinfret, S., Sarrafzadegan, N., Sharma, S., Lauzon, C., et al. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2011.07.616 · Cited by 12
Belief about drug assignment and abstinence in treatment of cigarette smoking using nortriptyline
Hall, S., Gorecki, J. A., Reus, V. I., Humfleet, G. L., & Muñoz, R. F. (2007) · Nicotine & Tobacco Research · doi:10.1080/14622200701239480 · Cited by 9
Nicotine reduction: Effectiveness of bupropion
Neumann, J. K., Peeples, B., East, J., & Ellis, A. R. (2000) · The British Journal of Psychiatry · doi:10.1192/bjp.177.1.87-a · Cited by 9
Antidepressants and Smoking Cessation
Gambassi, G., & Bernabei, R. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.11.1257 · Cited by 8
Zyban ® – is there a cause for concern?
Tracey, J. (2002) · Expert Opinion on Drug Safety · doi:10.1517/14740338.1.4.303 · Cited by 8
The “Bupropion for Smoking Cessation” Trial From a Family Practice Perspective
Caplan, B. J. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.4.470-a · Cited by 8
Wyniki leczenia uzależnienia od nikotyny chorych na przewlekłą obturacyjną chorobę płuc
Górecka, D., Bednarek, M., Nowiński, A., Puścińska, E., Goljan-Giermek, A., & Zielinski, J. (2008) · Pneumonologia i Alergologia Polska · doi:10.5603/arm.28222 · Cited by 8
Kras, M., Stough, C. K. K., Scholey, A. B., Kure, C., & Camfield, D. (2010) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(10)70930-5 · Cited by 7
Impairment of memory by fluoxetine in smokers.
Stein, R. A., Jarvik, M. E., & Gorelick, D. A. (1993) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.1.1-4.188 · Cited by 7
Comparing the Tolerability and Effectiveness of Two Treatment Regimens in a Smoking Clinic
Sherman, S. E., Aldana, I., Estrada, M., & York, L. S. (2008) · Military Medicine · doi:10.7205/milmed.173.6.550 · Cited by 6
Adherence to Pharmacological Smoking Cessation Treatment among Weight-Concerned Women
Raynor, D. A. (2004) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 5
Nicotine Reduction and Bupropion
Neumann, J. K., Peeples, B., & Seneker, A. (2002) · CHEST Journal · doi:10.1378/chest.121.4.1378 · Cited by 5
Ionescu, D., & Cristescu, C. (2008) · Toxicology Letters · doi:10.1016/j.toxlet.2008.06.751 · Cited by 4
Bupropion assists with tobacco cessation in adolescents but relapse is high
Best, D. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2008.02.021 · Cited by 4
High effectiveness of short treatment with bupropion for smoking cessation in general care
Breitling, L. P., Twardella, D., & Brenner, H. (2008) · Thorax · doi:10.1136/thx.2007.092908 · Cited by 4
Grandi, S. M., Filion, K. B., Gervais, A., Joseph, L., O’Loughlin, J. L., Paradis, G., Pilote, L., Rinfret, S., & Eisenberg, M. J. (2012) · Circulation · doi:10.1161/circ.125.suppl_10.ap323 · Cited by 4
Perceived Treatment Assignment and Smoking Cessation in a Clinical Trial of Bupropion
Buchanan, T., Cox, L., Nollen, N. L., Thomas, J. L., Berg, C., Mayo, M., & Ahluwalia, J. S. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0098 · Cited by 3
Cited by
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457
Chaikof, E. L., Dalman, R. L., Eskandari, M. K., Jackson, B. M., Lee, W. A., Mansour, M. A., Mastracci, T. M., Mell, M., Murad, M. H., Nguyen, L. L., et al. (2018) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2017.10.044 · Cited by 2,751
Authors/Task Force Members, Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316653709 · Cited by 1,334
Anthenelli, R. M., Benowitz, N. L., West, R., St Aubin, L., McRae, T., Lawrence, D., Ascher, J., Russ, C., Krishen, A., & Evins, A. E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30272-0 · Cited by 1,177
Electronic cigarettes for smoking cessation
Hartmann-Boyce, J., McRobbie, H., Bullen, C., Begh, R., Stead, L. F., & Hajek, P. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010216.pub3 · Cited by 1,002
Self-citation
Metadata
- Authors
- Hughes, J. R., Stead, L. F., Hartmann-Boyce, J., Cahill, K., & Lancaster, T.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2014-01-08
- Issue
- 1
- Pages
- CD000031-CD000031
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W4210565407
- Cited by
- 348
- References
- 326
- FWCI
- 32.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.